MONOPHARMA

Mono Pharmacare Share Price

₹32.00 -1.25 (-3.76%)

21 Nov, 2024 14:48

SIP TrendupStart SIP in MONOPHARMA

Start SIP

Performance

  • Low
  • ₹32
  • High
  • ₹32
  • 52 Week Low
  • ₹32
  • 52 Week High
  • ₹75
  • Open Price₹32
  • Previous Close₹33
  • Volume4,000

Investment Returns

  • Over 1 Month -7.38%
  • Over 3 Month -14.67%
  • Over 6 Month -28.25%
  • Over 1 Year -31.33%
SIP Lightning

Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!

Invest Now

Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 57
  • P/B Ratio
  • 2
  • Average True Range
  • 1.28
  • EPS
  • 1.38
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.59
  • RSI
  • 41.44
  • MFI
  • 29.1

Mono Pharmacare Financials

Mono Pharmacare Technicals

EMA & SMA

Current Price
₹32.00
-1.25 (-3.76%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹35.21
  • 50 Day
  • ₹36.61
  • 100 Day
  • ₹38.99
  • 200 Day
  • ₹42.85

Resistance and Support

33.73 Pivot Speed
  • R3 35.67
  • R2 35.18
  • R1 34.22
  • S1 32.77
  • S2 32.28
  • S3 31.32

What's your outlook on Mono Pharmacare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mono Pharmacare Ltd has an operating revenue of Rs. 246.07 Cr. on a trailing 12-month basis. An annual revenue growth of 350% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 8% is fair but needs improvement. The company has a debt to equity of 61%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 18 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Others To consider other business matters.
2024-08-06 Others To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters.
2024-04-29 Others To consider other business matters

Mono Pharmacare F&O

Mono Pharmacare Shareholding Pattern

56.72%
35.27%
8.01%

About Mono Pharmacare

  • NSE Symbol
  • MONOPHARMA
  • BSE Symbol
  • Managing Director
  • Mr. Panilam Lakhatariya
  • ISIN
  • INE0OIP01012

Similar Stocks to Mono Pharmacare

Mono Pharmacare FAQs

Mono Pharmacare share price is ₹32 As on 21 November, 2024 | 14:34

The Market Cap of Mono Pharmacare is ₹56.5 Cr As on 21 November, 2024 | 14:34

The P/E ratio of Mono Pharmacare is As on 21 November, 2024 | 14:34

The PB ratio of Mono Pharmacare is 2 As on 21 November, 2024 | 14:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23